$OVTZ
OCULUS VISIONTECH INC.

2021 Q3 Form 10-Q Financial Statement

#000143774921018469 Filed on August 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $113.6K $122.1K $37.08K
YoY Change 35.89% 229.3% -46.63%
% of Gross Profit
Research & Development $295.8K $147.4K $35.33K
YoY Change 217.18% 317.3%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $409.4K $269.6K $72.42K
YoY Change 131.48% 272.24% 4.22%
Operating Profit -$578.8K -$483.7K -$84.42K
YoY Change 94.9% 473.04% 21.49%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$578.8K -$483.7K -$84.42K
YoY Change 94.91% 473.02%
Income Tax
% Of Pretax Income
Net Earnings -$578.8K -$483.7K -$84.42K
YoY Change 94.9% 473.04% 21.49%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$6.331K -$5.354K -$1.174K
COMMON SHARES
Basic Shares Outstanding 91.42M 91.42M 67.02M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.707M $3.063M $869.4K
YoY Change 288.98% 252.3% 82.8%
Cash & Equivalents $2.707M $3.063M $869.4K
Short-Term Investments
Other Short-Term Assets $2.400K $12.86K $3.070K
YoY Change -48.83% 318.89% 36.44%
Inventory
Prepaid Expenses $2.403K $7.500K
Receivables
Other Receivables
Total Short-Term Assets $2.716M $3.076M $872.5K
YoY Change 287.73% 252.54% 82.58%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $1.967M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.00 -$4.00 $1.967M
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $2.716M $3.076M $872.5K
Total Long-Term Assets $2.00 -$4.00 $1.967M
Total Assets $2.716M $3.076M $2.839M
YoY Change 1.83% 8.33% 494.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $60.00K $59.31K $51.91K
YoY Change 18.55% 14.26% 17.31%
Accrued Expenses $49.08K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $244.8K $195.1K $181.2K
YoY Change 31.57% 7.67% 14.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $244.8K $195.1K $181.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $244.8K $195.1K $181.2K
YoY Change 31.56% 7.67% 14.04%
SHAREHOLDERS EQUITY
Retained Earnings -$45.62M -$45.04M -$41.54M
YoY Change 9.02% 8.41% 0.55%
Common Stock $47.67M $47.50M $43.79M
YoY Change 8.57% 8.48% 5.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.471M $2.881M $2.658M
YoY Change
Total Liabilities & Shareholders Equity $2.716M $3.076M $2.839M
YoY Change 1.83% 8.33% 494.18%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$578.8K -$483.7K -$84.42K
YoY Change 94.9% 473.04% 21.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$356.3K -$297.9K -$344.7K
YoY Change 105.27% -13.58% -51.24%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $114.2K
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $114.2K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 3.062M 773.0K
YoY Change 296.13% -34.3%
NET CHANGE
Cash From Operating Activities -356.3K -297.9K -344.7K
Cash From Investing Activities 0.000 0.000 114.2K
Cash From Financing Activities 0.000 3.062M 773.0K
Net Change In Cash -356.3K 2.764M 542.5K
YoY Change 105.27% 409.57% 15.49%
FREE CASH FLOW
Cash From Operating Activities -$356.3K -$297.9K -$344.7K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
91422569
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2020Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91422569
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91422569
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86522569
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86522569
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3062944 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
490190 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12862 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6082 USD
CY2021Q2 us-gaap Assets
Assets
3075806 USD
CY2020Q4 us-gaap Assets
Assets
496272 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
59311 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32329 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
135759 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
135738 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
195070 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
168067 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
47503149 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
44073257 USD
CY2021Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
414128 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
414128 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45036541 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44159180 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2880736 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
328205 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3075806 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
496272 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 USD
CY2021Q2 ovtz Consulting Expense
ConsultingExpense
24021 USD
CY2020Q2 ovtz Consulting Expense
ConsultingExpense
12000 USD
ovtz Consulting Expense
ConsultingExpense
24021 USD
ovtz Consulting Expense
ConsultingExpense
12000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
147445 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35333 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
280169 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36910 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
122119 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37084 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
205525 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
108842 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
190156 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
367646 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
483741 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
84417 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
96 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-483741 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-84417 USD
us-gaap Net Income Loss
NetIncomeLoss
-877361 USD
us-gaap Net Income Loss
NetIncomeLoss
-157656 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-84417 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-877361 USD
us-gaap Costs And Expenses
CostsAndExpenses
877361 USD
us-gaap Costs And Expenses
CostsAndExpenses
157752 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-483741 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-157752 USD
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 USD
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
96 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
90357352
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71897568
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
88482569
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67022568
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
248303 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
773038 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1380427 USD
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
414128 USD
us-gaap Net Income Loss
NetIncomeLoss
-157656 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2658240 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
328205 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3098616 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
36370 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
367646 USD
us-gaap Net Income Loss
NetIncomeLoss
-877361 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2880736 USD
us-gaap Net Income Loss
NetIncomeLoss
-877361 USD
us-gaap Net Income Loss
NetIncomeLoss
-157656 USD
us-gaap Share Based Compensation
ShareBasedCompensation
367646 USD
us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6780 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1804 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
26982 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-718 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
21 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-240071 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-489492 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-400249 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
114169 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
114169 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3098616 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
773038 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
36370 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
-0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3062246 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
773038 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2572754 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
490190 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
382452 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3062944 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
869410 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
0 USD
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
1380427 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
-0 USD
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
1966939 USD
us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1
0
us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Warrants Issued1
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1
414128
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
486958 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
172384 USD
us-gaap Net Income Loss
NetIncomeLoss
-877361 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-2772484 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-192865 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45036541 USD
CY2021Q2 ovtz Working Capital Deficit
WorkingCapitalDeficit
2880736 USD
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91422569
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86522569
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12862 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6082 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7500 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1030 USD
CY2021Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5362 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5052 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
59311 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16670 USD
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
0 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
15659 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
59311 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32329 USD
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1966939 USD
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000

Files In Submission

Name View Source Status
0001437749-21-018469-index-headers.html Edgar Link pending
0001437749-21-018469-index.html Edgar Link pending
0001437749-21-018469.txt Edgar Link pending
0001437749-21-018469-xbrl.zip Edgar Link pending
ex_270398.htm Edgar Link pending
ex_270399.htm Edgar Link pending
ex_270400.htm Edgar Link pending
ex_270401.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ovtz-20210630.xsd Edgar Link pending
ovtz-20210630_cal.xml Edgar Link unprocessable
ovtz-20210630_def.xml Edgar Link unprocessable
ovtz-20210630_lab.xml Edgar Link unprocessable
ovtz-20210630_pre.xml Edgar Link unprocessable
ovtz20210630_10q.htm Edgar Link pending
ovtz20210630_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending